Marchex INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Marchex, Inc. reported a decrease in revenue for the first quarter of 2026 compared to the prior year, alongside progress on a strategic acquisition.
NASDAQ
Marchex, Inc. reported a revenue decline in Q3 2025 and for the nine months ended September 30, 2025, while announcing an Agreement in Principle to acquire Archenia, Inc. for $10 million in convertible notes and potential earnout shares.
NASDAQ
Marchex, Inc. reported a net income of $85,000 for Q2 2025, a significant improvement from a prior year loss, despite a 3% revenue decrease.
NASDAQ
Marchex's Q1 2025 revenue decreased slightly to $11.4 million, impacted by lower call volumes and customer consolidation, while the company underwent reorganization efforts.
NASDAQ
Marchex's Q3 2024 results show a slight revenue decrease but a significant improvement in net loss compared to the same period last year.
NASDAQ
Marchex's Q2 2024 results show a revenue decrease of 3% year-over-year, alongside reduced operating expenses as the company continues its strategic realignment.
NASDAQ
Marchex's first quarter 2024 results show a revenue decrease of 5% year-over-year, alongside reduced operating expenses as the company focuses on strategic initiatives.
NASDAQ
Marchex has filed an amendment to its Q1 2023 quarterly report to include a missing exhibit, while also reporting a net loss of $4.5 million for the quarter.
NASDAQ
Marchex has filed an amendment to its June 30, 2023 quarterly report to include re-executed exhibits, with no changes to the financial statements or other disclosures.
NASDAQ
Marchex files an amended 10-Q report to correct a referencing error in an exhibit, while also reporting a 7% year-over-year revenue decrease for the first half of 2023.
NASDAQ
Marchex files an amended quarterly report to correct errors in exhibits related to certifications by the principal executive and financial officers.